Status:
UNKNOWN
Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Urothelial Carcinoma
Eligibility:
All Genders
Brief Summary
To study the association between aristolochic acid and urothelial carcinoma in Taiwan
Eligibility Criteria
Inclusion
- the resected kidney tissue in the tissue bank
Exclusion
- the patients who had been ever exposed to arsenics, rubber, chemicals, irradiation for pelvis, or received chemotherapy.
Key Trial Info
Start Date :
March 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00867633
Start Date
March 1 2009
End Date
March 1 2012
Last Update
February 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100